Prescription drug · NDA
Cysview (Hexaminolevulinate hydrochloride) NDC 10511-3001
Kit · Photocure Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 10511-3001-2 | 10511300102 | 1 KIT in 1 CARTON (10511-3001-2) * 50 mL in 1 SYRINGE, PLASTIC * 50 mL in 1 VIAL, GLASSMarketed from May 1, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cysview
- Generic name (nonproprietary)
- hexaminolevulinate hydrochloride
- Dosage form
- Kit
- Labeler
- Photocure Inc.NDC labeler code 10511
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022555
- Marketing start
- Listing expires
- Identifiers
- Product ID 10511-3001_49603d9a-adbb-4f38-a35f-d4e969c92a79SPL ID 49603d9a-adbb-4f38-a35f-d4e969c92a79SPL set ID 5aeed40d-6841-4adf-8940-f51d439fdfa3UPC 0310511300125
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N410511300102followed by a unit qualifier and the quantityPackage 10511-3001-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
CYSVIEW is indicated for the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (CIS), in adult patients: With suspected or known lesion(s) based on a prior cystoscopy Undergoing surveillance cystoscopy for bladder cancer Limitations of Use CYSVIEW is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer [see Warnings and Precautions (5.2) ] . CYSVIEW is an optical imaging agent indicated for the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (CIS), in adult patients: With suspected or known lesion(s) on the basis of a prior cystoscopy Undergoing surveillance cystoscopy for bladder…
Excerpt only. Read the full label for complete information.
About NDC 10511-3001
- What is NDC 10511-3001?
- 10511-3001 is the product NDC for Cysview (hexaminolevulinate hydrochloride) kit, listed with the FDA by Photocure Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cysview (Hexaminolevulinate hydrochloride).
- Who is the labeler?
- Photocure Inc., NDC labeler code 10511. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cysview?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.